AVADEL PHARMACEUTICALS PLC's ticker is AVDL and the CUSIP is 05337M104. A total of 80 filers reported holding AVADEL PHARMACEUTICALS PLC in Q1 2021. The put-call ratio across all filers is 0.96 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $37,000 | -82.0% | 3,575 | -71.3% | 0.00% | – |
| Q2 2023 | $205,000 | – | 12,460 | +6130.0% | 0.00% | – |
| Q2 2022 | $0 | -100.0% | 200 | -70.0% | 0.00% | – |
| Q1 2022 | $4,000 | -42.9% | 667 | -10.3% | 0.00% | – |
| Q4 2021 | $7,000 | -30.0% | 744 | -20.7% | 0.00% | – |
| Q3 2021 | $10,000 | +400.0% | 938 | +122.8% | 0.00% | – |
| Q2 2021 | $2,000 | -60.0% | 421 | -18.4% | 0.00% | – |
| Q1 2021 | $5,000 | -16.7% | 516 | -40.6% | 0.00% | – |
| Q4 2020 | $6,000 | +500.0% | 869 | -13.1% | 0.00% | – |
| Q1 2019 | $1,000 | 0.0% | 1,000 | +300.0% | 0.00% | – |
| Q4 2018 | $1,000 | -95.5% | 250 | -95.0% | 0.00% | – |
| Q3 2018 | $22,000 | -35.3% | 5,000 | -9.6% | 0.00% | – |
| Q2 2018 | $34,000 | -41.4% | 5,532 | -31.2% | 0.00% | – |
| Q1 2018 | $58,000 | +18.4% | 8,038 | +33.3% | 0.00% | – |
| Q4 2017 | $49,000 | -23.4% | 6,029 | +0.5% | 0.00% | – |
| Q3 2017 | $64,000 | -3.0% | 6,000 | 0.0% | 0.00% | – |
| Q2 2017 | $66,000 | +13.8% | 6,000 | -1.3% | 0.00% | – |
| Q1 2017 | $58,000 | – | 6,077 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WEALTH EFFECTS LLC | 2,409,289 | $24,815,676 | 12.25% |
| Knoll Capital Management, LLC | 600,000 | $6,180,000 | 6.42% |
| Vivo Capital, LLC | 4,096,428 | $42,193,208 | 4.62% |
| GENDELL JEFFREY L | 5,615,350 | $57,838,105 | 3.29% |
| Tri Locum Partners LP | 983,602 | $10,131,101 | 3.24% |
| Samsara BioCapital, LLC | 967,527 | $9,965,528 | 3.05% |
| MPM BioImpact LLC | 664,224 | $6,841,507 | 1.83% |
| COWEN AND COMPANY, LLC | 2,338,302 | $24,084,510 | 1.68% |
| RTW INVESTMENTS, LP | 7,136,415 | $73,505,075 | 1.55% |
| TANG CAPITAL MANAGEMENT LLC | 1,000,000 | $10,300,000 | 1.45% |